Our | Products


CABAZIL





THERAPEUTIC AREA: Oncology / Hematology
ACTIVE PRINCIPLE: Cabazitaxel
PRESENTATION: 0,50 mg x 28 hard capsules
INDICATION:

  • Prostate Cancer